View Document Preview and Link Document Date: 2015-03-06 00:23:42 Open Document File Size: 151,35 KB Share Result on Facebook
Company Eisai Australia Pty Limited / TPC group / Cox / ITT / / Country Australia / / Currency USD / / Event FDA Phase / / Facility Chemotherapy Program Private Hospital / / IndustryTerm proposed clinical management algorithm / chemotherapy products / proposed clinical algorithm / treatment of cancer / eribulin / treatment algorithm / / MedicalCondition tumor / advanced disease / HER2 positive breast cancer / leukopenia and peripheral neuropathy / cancer / neutropenia / metastatic breast cancer / febrile neutropenia / breast cancer / / MedicalTreatment hormonal therapy / chemotherapy / radiotherapy / / Organization Private Clinic Authority / Chemotherapy Program Private Hospital / Public Hospital Authority / / Person Vinorelbine / / Position investigator / Physician / Trial ID/ First author / / Product carboplatin / cisplatin / etoposide / letrozole / cyclophosphamide / exemestane / fluorouracil / mitomycin / E389-A001 / Halichondrin B Analog / Eribulin Mesylate / / PublishedMedium Journal of Clinical Oncology / / Technology proposed clinical management algorithm / 7 Proposed treatment algorithm / Chemotherapy / proposed clinical algorithm / / SocialTag 
Microsoft Word[removed]Eribulin Eisai PSD March 13 final.docx